BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 12404880)

  • 21. Effect of imatinib mesilate on the disposition kinetics of ciclosporin in rats.
    Kajita T; Higashi Y; Imamura M; Maida C; Fujii Y; Yamamoto I; Miyamoto E
    J Pharm Pharmacol; 2006 Jul; 58(7):997-1000. PubMed ID: 16805961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disposition and metabolism of [14C]-haloperidol in rats.
    Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M
    Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 6th communication: interspecies comparison of pharmacokinetics and excretion of imidapril metabolites in rats, dogs, and monkeys.
    Yamada Y; Endo M; Kohno M; Otsuka M; Takaiti O
    Arzneimittelforschung; 1992 Apr; 42(4):499-506. PubMed ID: 1642673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of intravenous methylprednisolone pulse treatment on the disposition of ciclosporin and hepatic CYP3A activity in rats.
    Konishi H; Sumi M; Shibata N; Takada K; Minouchi T; Yamaji A
    J Pharm Pharmacol; 2004 Apr; 56(4):477-83. PubMed ID: 15099443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatobiliary excretion of berberine.
    Tsai PL; Tsai TH
    Drug Metab Dispos; 2004 Apr; 32(4):405-12. PubMed ID: 15039293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs.
    Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF
    Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose-dependent pharmacokinetics of 1-(2-deoxy-beta-D- ribofuranosyl)-2,4-difluoro-5-iodobenzene: a potential mimic of 5-iodo-2'-deoxyuridine.
    Khalili P; Naimi E; Sun WY; Knaus EE; Wiebe LI
    Biopharm Drug Dispos; 2003 Dec; 24(9):385-95. PubMed ID: 14689467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
    Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
    Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of pharmacokinetics of M1, M2, M3, and M4 after intravenous administration of DA-125 or ME2303 to mice and rats. New adriamycin analogues containing fluorine.
    Yoon EJ; Lee WI; Shim HJ; Lee SD; Kim WB; Yang J; Lee MG
    Biopharm Drug Dispos; 1996 Jul; 17(5):373-420. PubMed ID: 8830976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of a new endothelin receptor antagonist, TAK-044, on myocardial stunning in dogs.
    Kitayoshi T; Ikeda S; Kubo K; Awane-Igata Y; Watanabe T; Fujino M
    Eur J Pharmacol; 1996 Jun; 305(1-3):137-43. PubMed ID: 8813544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of pinokalant, a new nonselective cation channel blocker in the rat.
    Leusch A; Eichhorn B; Busch U; Ensinger HA
    Arzneimittelforschung; 2001; 51(12):947-54. PubMed ID: 11799840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High performance liquid chromatographic analysis an pharmacokinetic characteristics of ID-7181, a novel quaternary ammoniopropenyl cephalosporin, following intravenous and intramuscular injections to rats.
    Yoo BI; Yeom ZH; Kanga MH; Kwon OS; Kang JH; Yu SW; Moon DC; Song S; Chung YB
    Arzneimittelforschung; 2005; 55(9):549-56. PubMed ID: 16229120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of endothelin antagonist (TAK-044) on cerebral ischemic volume, oxidative stress markers and neurobehavioral parameters in the middle cerebral artery occlusion model of stroke in rats.
    Gupta YK; Briyal S; Sharma U; Jagannathan NR; Gulati A
    Life Sci; 2005 May; 77(1):15-27. PubMed ID: 15848215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absorption, distribution, metabolism and excretion of [carbonyl-14C]mosapride citrate after repeated oral administration in rats.
    Matsumoto S; Tagawa M; Hatoyama T; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1103-8. PubMed ID: 8267677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic study of [14C]flutrimazole after oral and intravenous administration in dogs. Comparison with clotrimazole.
    Conte L; Ramis J; Mis R; Vilageliu J; Basi N; Forn J
    Arzneimittelforschung; 1992 Jun; 42(6):854-8. PubMed ID: 1418045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of curcumin on cyclosporin-induced reduction of biliary bilirubin and cholesterol excretion and on biliary excretion of cyclosporin and its metabolites.
    Deters M; Siegers C; Hänsel W; Schneider KP; Hennighausen G
    Planta Med; 2000 Jun; 66(5):429-34. PubMed ID: 10909262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The disposition and pharmacokinetics of alpidem, a new anxiolytic, in the rat.
    Garrigou-Gadenne D; Durand A; Thenot JP; Morselli PL
    Drug Metab Dispos; 1991; 19(3):574-9. PubMed ID: 1680622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipients.
    Mück W; Mai I; Fritsche L; Ochmann K; Rohde G; Unger S; Johne A; Bauer S; Budde K; Roots I; Neumayer HH; Kuhlmann J
    Clin Pharmacol Ther; 1999 Mar; 65(3):251-61. PubMed ID: 10096257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.